NASDAQ: MRUSMerus Nv Stock Ownership - Who owns Merus Nv?
Insider buying vs selling
Have Merus Nv insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| A. Genmab | 10% Owner | 2025-12-17 | 150,795 | $97.00 | $14.63MBuy |
| A. Genmab | 10% Owner | 2025-12-16 | 120,752 | $97.00 | $11.71MBuy |
| Mark T. Iwicki | Director | 2025-12-12 | 73,576 | $97.00 | $7.14MSell |
| Harry Shuman | VP Controller PAO | 2025-12-12 | 11,002 | $97.00 | $1.07MSell |
| Sven Ante Lundberg | President CEO PEO | 2025-12-12 | 30,297 | $97.00 | $2.94MSell |
| Sven Ante Lundberg | President CEO PEO | 2025-12-12 | 16,372 | $97.00 | $1.59MSell |
| Sven Ante Lundberg | President CEO PEO | 2025-12-12 | 9,191 | $97.00 | $891.53kSell |
| Sven Ante Lundberg | President CEO PEO | 2025-12-12 | 9,192 | $97.00 | $891.62kSell |
| Sven Ante Lundberg | President CEO PEO | 2025-12-12 | 9,191 | $97.00 | $891.53kSell |
| Sven Ante Lundberg | President CEO PEO | 2025-12-12 | 9,192 | $97.00 | $891.62kSell |
MRUS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MRUS insiders and whales buy or sell their stock.
MRUS Shareholders
What type of owners hold Merus Nv stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| A. Genmab | 188.80% | 143,197,701 | $13.89B | Insider |
| Paradigm Biocapital Advisors LP | 5.77% | 4,373,770 | $424.30M | Institution |
| Incyte Corp | 4.68% | 3,550,000 | $344.39M | Insider |
| Avoro Capital Advisors LLC | 4.67% | 3,542,500 | $343.66M | Institution |
| Commodore Capital LP | 4.65% | 3,525,000 | $341.96M | Institution |
| Deerfield Management Company LP | 4.02% | 3,046,916 | $295.58M | Institution |
| Hbk Investments L P | 3.76% | 2,850,000 | $276.48M | Institution |
| Fmr LLC | 3.71% | 2,810,935 | $272.69M | Institution |
| Blackrock Inc | 2.86% | 2,172,015 | $210.71M | Institution |
| Westfield Capital Management Co LP | 2.81% | 2,132,489 | $206.87M | Institution |
MRUS vs Biotech Stocks
Merus Nv Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.